Table 3

Base case costs, effectiveness and incremental cost-effectiveness ratios per 1000 cases treated

StrategyCost (US$)Incremental cost (US$)Number of surgeries avoidedAdditional surgeries avoidedIncremental C/E
S-ESD4 224 464925
WF-EMR4 334 561110 097906−19$ than S-ESD
<surgeries avoided than S-ESD
U-ESD6 911 7972 687 33393813210 112
(compared with S-ESD)
  • C/E, cost effectiveness; ESD, endoscopic submucosal dissection; S-ESD, selective ESD; U-ESD, universal ESD; WF-EMR, wide-field endoscopic mucosal resection.